THROMGEN INC has a total of 11 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KOLLTAN PHARMACEUTICALS INC, HENLIUS BIOTECH CO LTD and SIAMAB THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Canada | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Schmaier Alvin H | 10 |
#2 | Hasan Ahmed A K | 8 |
#3 | Mosberg Henry I | 2 |
#4 | Marques Fernanda F | 2 |
#5 | Hilfinger John | 2 |
Publication | Filing date | Title |
---|---|---|
US7074765B2 | Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 | |
US6544750B1 | Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |